Many patients are yet to benefit from the advances and approaches now at our disposal for the management of type 2 diabetes. How can the gaps and delays be addressed?
Maintaining glycated hemoglobin levels within target range may reduce the risk for developing Alzheimer’s disease and related dementias in older men with diabetes.
The use of diabetes therapeutic technology is being advocated for older people, but what are the benefits and challenges of implementing technology solutions in older individuals with diabetes?
How might fixed-ratio combinations of basal insulins and GLP-1 receptor agonists be used to optimize treatment of type 2 diabetes? Find out more in this expert opinion paper.
Update on the epidemiology, pathophysiology, and clinical presentation of DKA and HHS in adults with diabetes, with recommendations for diagnosis, treatment, and prevention.
Our tailored content service will keep you up to date…
Receive newsletters curated for the busy specialist by our expert editorial team
With the growing importance of primary care in diabetes, this podcast discusses the evidence on continuous glucose monitoring (CGM) use, the role of primary healthcare, and practical tips for interpreting the ambulatory glucose profile (AGP) report.
EIAS can cause hyperglycemia, hypoglycemia, and ketoacidosis in people with diabetes. This case in an older adult with type 1 diabetes shows how EIAS can be managed in an outpatient setting.
Intermittently scanning CGM detected hypoglycemia in a woman previously diagnosed with schizophrenia and treated with antipsychotic medication. Insulinoma was diagnosed and resected, resolving her neuropsychiatric symptoms.
A diagnosis of glycogen storage disease type IX is easy to overlook, but it should be considered in children presenting with unexplained hepatomegaly and elevated transaminase levels. Genetic analysis is vital for accurate diagnosis.
An expert-led symposium exploring the prevention and management of type 2 diabetes through dietary interventions. Highlights include discussion of the recent EASD guidelines, therapeutic diets, food types and processing, plus psychological factors that influence patient success, and the drivers of healthy eating and diabetes control.
Challenges and fears related to managing glucose levels around planned and spontaneous exercise affect outcomes and quality of life in people living with type 1 diabetes. Advances in technology, including continuous glucose monitoring, open-loop …
Preliminary evidence (including data from our institution) on use of real-time continuous glucose monitoring (rtCGM) in the hospital setting is encouraging, however questions remain regarding the ideal approach for utilization within health …
Diabetes is the leading cause and a common comorbidity of advanced chronic kidney disease. Glycaemic management in this population is challenging and characterised by frequent excursions of hypoglycaemia and hyperglycaemia. Current glucose …
The defining characteristic of both type 1 diabetes (T1D) and type 2 diabetes (T2D) is abnormally elevated levels of blood glucose (hyperglycemia), and glycemic control has traditionally been assessed by periodically measuring glycated hemoglobin …
Despite the availability of new classes of glucose-lowering drugs, insulin therapy still represents a cornerstone of the treatment for type 2 diabetes mellitus (T2D), and many patients eventually require and benefit from insulin therapy.
Postprandial metabolic responses to a mixed-macronutrient meal typically include a shift from predominantly fat to predominantly carbohydrate metabolism. This shift is reflected by a transient increase in circulating glucose concentrations, caused …
Bariatric surgery is the most effective therapy for severe obesity. However, there is a considerable chance of long-term side effects after surgery. Recent research indicates that approximately one-third of individuals subjected to gastric bypass …
